Jinpei Zhou

1.7k total citations
90 papers, 1.4k citations indexed

About

Jinpei Zhou is a scholar working on Molecular Biology, Hematology and Organic Chemistry. According to data from OpenAlex, Jinpei Zhou has authored 90 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Molecular Biology, 21 papers in Hematology and 19 papers in Organic Chemistry. Recurrent topics in Jinpei Zhou's work include Protein Degradation and Inhibitors (20 papers), Multiple Myeloma Research and Treatments (16 papers) and Ubiquitin and proteasome pathways (13 papers). Jinpei Zhou is often cited by papers focused on Protein Degradation and Inhibitors (20 papers), Multiple Myeloma Research and Treatments (16 papers) and Ubiquitin and proteasome pathways (13 papers). Jinpei Zhou collaborates with scholars based in China, Austria and Germany. Jinpei Zhou's co-authors include Huibin Zhang, Xinrui Yuan, Hong Bu, Chao‐Yie Yang, Wenlong Huang, Lingyun Yang, Leilei Zhao, Qing Li, Xiaojun Yang and Yifei Yang and has published in prestigious journals such as Diabetes, Biochemical and Biophysical Research Communications and Journal of Medicinal Chemistry.

In The Last Decade

Jinpei Zhou

90 papers receiving 1.4k citations

Peers

Countries citing papers authored by Jinpei Zhou

Since Specialization

Citations

This map shows the geographic impact of Jinpei Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinpei Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinpei Zhou more than expected).

Fields of papers citing papers by Jinpei Zhou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jinpei Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinpei Zhou. The network helps show where Jinpei Zhou may publish in the future.

Co-authorship network of co-authors of Jinpei Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Jinpei Zhou. A scholar is included among the top collaborators of Jinpei Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jinpei Zhou. Jinpei Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Design, Synthesis, and Biological Evaluation of Eukaryotic Initiation Factor 2B (eIF2B) Activators 2024 ·ChemMedChem ·(unknown), S. M. Liu, Lixun Wang, Chao Chen, Mengqiu Hu, Yi Xue, (unknown), (unknown), (unknown), Jinpei Zhou, Huibin Zhang	1
2	Design, synthesis and biological evaluation of KRASG12C-PROTACs 2023 ·Bioorganic & Medicinal Chemistry ·Xiaoyi Zhang, Tong Zhao, Minghao Sun, Pei Li, Mengzhen Lai, (unknown), Jiaying Chen, Jian Ding, Hua Xie, Jinpei Zhou, Huibin Zhang	21
3	Structural insights into a shared mechanism of human STING activation by a potent agonist and an autoimmune disease-associated mutation 2022 ·Cell Discovery ·Zuoquan Xie, Zhen Wang, (unknown), Jinpei Zhou, (unknown), Qingxia Wang, Xiyuan Wang, (unknown), Yan Zhang, (unknown), (unknown), Hui Xu, (unknown), (unknown), Jian Ding, Huibin Zhang, Wenhu Duan, Xuekui Yu, Meiyu Geng	33
4	Design, synthesis and biological evaluation of macrocyclic derivatives as TRK inhibitors 2021 ·Bioorganic & Medicinal Chemistry Letters ·Pei Li, (unknown), Tong Zhao, Lin Xu, (unknown), (unknown), Jinpei Zhou, Huibin Zhang	7
5	Design, synthesis and biological activity of bicyclic carboxamide derivatives as TRK inhibitors 2020 ·Bioorganic & Medicinal Chemistry ·Minghao Sun, (unknown), Pei Li, Fangqing Zhang, Huibin Zhang, Jinpei Zhou	7
6	Design, synthesis and biological evaluation of imidazolopyridone derivatives as novel BRD4 inhibitors 2020 ·Bioorganic & Medicinal Chemistry ·Yifei Yang, Pan Chen, Leilei Zhao, Bing Zhang, Changliang Xu, Huibin Zhang, Jinpei Zhou	3
7	Design and synthesis of Imidazo[1,2-b]pyridazine IRAK4 inhibitors for the treatment of mutant MYD88 L265P diffuse large B-cell lymphoma 2020 ·European Journal of Medicinal Chemistry ·(unknown), Gang Bai, Yi Ning, (unknown), Tao Zhang, Peiran Song, Jinpei Zhou, Wenhu Duan, Jian Ding, Hua Xie, Huibin Zhang	21
8	Design, synthesis and biological evaluation of pyridone–aminal derivatives as MNK1/2 inhibitors 2019 ·Bioorganic & Medicinal Chemistry ·Xinrui Yuan, (unknown), Hong Bu, (unknown), Jinpei Zhou, (unknown)	11
9	Exploiting the 7-methylimidazo[1,5-a]pyrazin-8(7H)-one scaffold for the development of novel chemical inhibitors for Bromodomain and Extraterminal Domain (BET) family 2019 ·Bioorganic Chemistry ·Yifei Yang, Pan Chen, Leilei Zhao, Fangqing Zhang, Bing Zhang, Changliang Xu, Huibin Zhang, Jinpei Zhou	10
10	Design, synthesis and biological evaluation of bicyclic carboxylic acid derivatives as IDO1 inhibitors 2019 ·Bioorganic Chemistry ·(unknown), Xiaojun Yang, Pan Chen, Xueting Liu, Jinpei Zhou, Huibin Zhang	9
11	Design, synthesis and biological evaluation of imidazo[1,5-a]pyrazin-8(7H)-one derivatives as BRD9 inhibitors 2019 ·Bioorganic & Medicinal Chemistry ·(unknown), Jian Zhang, Hui Ma, Xinrui Yuan, Pan Chen, Jinpei Zhou, Huibin Zhang	9
12	Design, synthesis and biological evaluation of novel spiro-pentacylamides as acetyl-CoA carboxylase inhibitors 2018 ·Bioorganic & Medicinal Chemistry ·(unknown), (unknown), Yifei Yang, Hui Ma, Hongyi Chen, Huibin Zhang, Jinpei Zhou	21
13	Design, synthesis and biological evaluation of 7-methylimidazo[1,5-a]pyrazin-8(7H)-one derivatives as BRD4 inhibitors 2017 ·Bioorganic & Medicinal Chemistry ·Leilei Zhao, Yifei Yang, Yahui Guo, Lingyun Yang, Jian Zhang, Jinpei Zhou, Huibin Zhang	14
14	Design and synthesis of thiourea derivatives containing a benzo[5,6]cyclohepta[1,2-b]pyridine moiety as potential antitumor and anti-inflammatory agents 2012 ·Bioorganic & Medicinal Chemistry Letters ·Wukun Liu, Jinpei Zhou, Tong Zhang, (unknown), Hai Qian, Huibin Zhang, Wenlong Huang, Ronald Gust	47
15	Investigations on cytotoxicity and anti-inflammatory potency of licofelone derivatives 2011 ·European Journal of Medicinal Chemistry ·Wukun Liu, Jinpei Zhou, Kerstin Bensdorf, Huibin Zhang, Haoran Liu, Yubin Wang, Hai Qian, Yanchun Zhang, (unknown), (unknown), Wenlong Huang, Can‐Cheng Guo, Ronald Gust	34
16	Licofelone–Nitric Oxide Donors as Anticancer Agents 2011 ·Archiv der Pharmazie ·Wukun Liu, Jinpei Zhou, Yinglin Liu, Haoran Liu, Kerstin Bensdorf, Can‐Cheng Guo, Ronald Gust	8
17	Synthesis and Biological Evaluation of Ezetimibe Analogs as Possible Cholesterol Absorption Inhibitors 2011 ·Letters in Drug Design & Discovery ·Yubin Wang, (unknown), Wenlong Huang, Huibin Zhang, Jinpei Zhou	9
18	The application of an aryl hydrazine linker prevents ß‐elimination side products in the SPPS of C‐terminal cysteine peptides 2010 ·Journal of Peptide Science ·Shuaijian Ni, Huibin Zhang, Wenlong Huang, Jinpei Zhou, Hai Qian, Wei Chen	11
19	Microwave-assisted solid phase synthesis, PEGylation, and biological activity studies of glucagon-like peptide-1(7–36) amide 2008 ·Bioorganic & Medicinal Chemistry ·(unknown), Huibin Zhang, Wenlong Huang, Jinpei Zhou, Yinghong Zhou, Hai Qian, Shuaijian Ni	21
20	Selective reduction of andrographolide 2003 ·Zhongguo yaowu huaxue zazhi ·Jinpei Zhou	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact